ArticleEuropean journal of clinical pharmacology2022
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.
Hideyuki Hibino et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it